The Europe Gelatin And Bone Glue Market, estimated at USD 272.5 Mn in 2025, is expected to exhibit a CAGR of 6.1% and reach USD 412.5 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The key market players are focusing on various growth strategies partnership and others for research and development activities, which in turn is expected to fuel the growth of Europe gelatin and bone glue market over the forecast period. For instance, in September 2025, Gelita, a global leader in gelatin and collagen products, joined forces with Azelis, a prominent distributor of specialty chemicals and ingredients, to establish a strategic partnership. This collaboration aims to distribute Gelita's extensive range of gelatin-based products across Europe, with a particular emphasis on France's pharmaceutical and nutraceutical industries.
Europe Gelatin and Bone Glue Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of drugs from one place to another.
COVID-19 pandemic had a notable impact on the gelatin and bone glue market in Europe. The region witnessed a decline in demand for gelatin and bone glue market due to the postponement or cancellation of elective surgeries and non-emergency procedures. Healthcare systems focused its resources on managing the pandemic, leading to a decreased emphasis on non-essential medical procedures. Additionally, disruptions in the global supply chain and transportation restrictions affected the production and distribution of gelatin and bone glue, potentially causing shortages or delays in availability. However, as the situation improves and healthcare systems regain capacity, it is expected that the market will gradually recover. The resumption of elective surgeries and the easing of supply chain disruptions will play a significant role in driving the market's resurgence in Europe.
Europe Gelatin and Bone Glue Market: Key Developments
In January 2025, Nitta Gelatin India, introduced a high-quality gelatin line in the HoReCa segment, aiming to meet international standards. The company expressed its commitment to providing culinary enthusiasts with the opportunity to create and savor a wide range of desserts, jellies, marshmallows, and other culinary delights of exceptional quality.
On January 12, 2025, Darling Ingredients Inc., a global leader in sustainable protein and fat products, has partnered with the Terasaki Institute for Biomedical Innovation (TIBI) to advance gelatin-based therapies. Through their collaboration, Rousselot Health, a brand of Darling Ingredients, will supply TIBI with X-Pure modified gelatins, facilitating valuable insights for TIBI's research and clinical trials. This partnership between industry expertise and innovative research aims to drive biomedical innovation forward.
In October, 2025, PB Leiner, a leading global provider of high-quality gelatin and collagen solutions for various industries announced its gelwoRx Dsolve pharmaceutical gelatin portfolio has been extended with three new products: Dsolve B, Dsolve P and Dsolve xTRA. The new variants have been specially designed to provide advanced solutions for reduced crosslinking and fast dissolution of soft caps.
Browse 28 Market Data Tables and 24 Figures spread through 178 Pages and in-depth TOC on Europe Gelatin and Bone Glue Market, Forecast to 2032, Europe Gelatin and Bone Glue Market, By Product Type (Gelatin (Acidic Pretreatment and Alkali Pretreatment) and Bone Glues (Synthetic Bone Glues and Natural Bone Glues), By Application (Arthroplasty, Sports Injuries, Spine Surgery, Trauma, and Others), and By End user (Hospitals, specialty clinics, and ambulatory surgical centers), and By Country (Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe).
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/europe-gelatin-and-bone-glue-market-3793
Key Takeaways of Europe Gelatin and Bone Glue Market:
- The Europe gelatin and bone glue market is expected to exhibit a CAGR of 6.1% during the forecast period. The European gelatin and bone glue market is experiencing substantial growth driven by multiple factors. Increasing demand across industries such as food, pharmaceuticals, and cosmetics is a primary driver. Gelatin's versatility as a gelling agent, stabilizer, and thickener in food products, along with bone glue's applications in orthopedic surgeries and wound healing, contribute to this growth. Moreover, there is a growing preference for natural and sustainable ingredients, leading to the utilization of organic and non-GMO sources for gelatin and bone glue production. Stringent regulations and quality standards implemented by the European Union ensure product safety and traceability, boosting consumer confidence. Technological advancements and ongoing research efforts are further expanding the functionalities and applications of gelatin and bone glue, presenting new opportunities in fields like tissue engineering and regenerative medicine
- Among Product type, the Europe gelatin and bone glue market is divided into two segments: Gelatin (acidic pretreatment and alkali pretreatment) and Bone Glues (synthetic bone glues and natural bone glues). Gelatin derived from acidic pretreatment holds the dominant position in the gelatin segment. In the bone glue segment, natural bone glues are favored due to their biocompatibility and adhesive properties.
- Among Application, in the European gelatin and bone glue marketis segmented into arthroplasty, sports injury, spine surgery, trauma, and others. Among these, arthroplasty and spine surgery have emerged as the dominant applications. The demand for joint replacements and interventions for spinal conditions is driving the growth of these segments. While sports injuries and trauma also hold significance, it is arthroplasty and spine surgery that play a prominent role in shaping the market dynamics in the European region.
- Major players operating in the Europe Gelatin and bone glue market, Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical, Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc
Contact Us